Prostate-specific antigen (PSA) testing has long been a subject of medical debate. A simple blood test designed to detect early signs of prostate cancer, PSA screening measures the level of PSA, a protein produced by the prostate gland.

Prostate-specific antigen (PSA) testing has long been a subject of medical debate. A simple blood test designed to detect early signs of prostate cancer, PSA screening measures the level of PSA, a protein produced by the prostate gland.
As men enter their 50s, proactive health management becomes increasingly important. One screening that often comes up is the PSA test—short for prostate-specific antigen. This simple blood test measures the level of PSA, a protein produced by the prostate gland.
Urinary incontinence is a frequent side effect of prostate cancer treatments, particularly major radical prostatectomy surgery. Although focal therapy for prostate cancer generally reduces the risk of urine incontinence, some men may still experience temporary urinary control issues. Fortunately, various strategies can help improve bladder control and enhance quality of life following prostate cancer treatment. […]
Prostate conditions, notably benign prostatic hyperplasia (BPH) and prostate cancer, significantly impact men’s health worldwide.
Advanced prostate cancer is usually detected late. Treatment options include higher-risk surgery, radiotherapy, hormone therapy or chemotherapy.
Men with early-stage prostate cancer could seek out focal therapy, an alternative to surgery and radiotherapy with few side effects.